Showing results (251-260 of 4,499) with videos related to

Sort By:
Pageof 450
Advances in Therapy|December 22, 2016
Cost-Effectiveness of Different Strategies for the Prevention of Venous Thromboembolism After Total Hip Replacement in ChinaXiaoyu Yan, Xiaohua Gu, Zhenxing Xu, et al.
Advances in Therapy|December 22, 2016
Relative Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor, Dacarbazine, and Glycoprotein 100 in Metastatic Melanoma: An Indirect Treatment ComparisonCasey Quinn, Qiufei Ma, Amber Kudlac, et al.
Advances in Therapy|March 26, 2017
A Case Series of Dacryoendoscopy in Childhood: A Diagnostic and Therapeutic Alternative for Complex Congenital Nasolacrimal Duct Obstruction Even in the First Year of LifeJens Heichel, Hans-Gert Struck, Miltiadis Fiorentzis, et al.
Advances in Therapy|April 25, 2014
Open-label study assessing the long-term efficacy and safety of triple olmesartan/amlodipine/hydrochlorothiazide combination therapy for hypertensionMassimo Volpe, Alejandro de la Sierra, Bettina Ammentorp, et al.
Advances in Therapy|February 25, 2017
Protocol for a Randomized Phase II Trial for Mesh Optimization by Autologous Plasma Coating in Prolapse Repair: IDEAL Stage 3Holger Gerullis, Dimitri Barski, Evangelos Georgas, et al.
Advances in Therapy|March 12, 2017
A Review of the Ahmed Glaucoma Valve Implant and Comparison with Other Surgical OperationsIvano Riva, Gloria Roberti, Andreas Katsanos, et al.
Advances in Therapy|February 17, 2017
Analyzing Health-Related Quality of Life Data to Estimate Parameters for Cost-Effectiveness Models: An Example Using Longitudinal EQ-5D Data from the SHIFT Randomized Controlled TrialAlison Griffiths, Noman Paracha, Andrew Davies, et al.
Advances in Therapy|February 18, 2017
The Role of the Pharmacist in Managing Type 2 Diabetes with Glucagon-Like Peptide-1 Receptor Agonists as Add-On TherapyJerry Meece
Advances in Therapy|February 22, 2017
Real-world Evidence for the Antianginal Efficacy of Trimetazidine from the Russian Observational CHOICE-2 StudyMaria Glezer,
Advances in Therapy|January 4, 2017
Mavoglurant Augmentation in OCD Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Proof-of-Concept, Randomized, Placebo-Controlled, Phase 2 StudyDaniel Rutrick, Dan J Stein, Ganesan Subramanian, et al.
Pageof 450